Alkermes plc (ALKS)
USD 28.87
(-3.98%)
USD 28.87
(-3.98%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.66 Billion USD | 49.61% |
| 2022 | 1.11 Billion USD | -5.28% |
| 2021 | 1.17 Billion USD | 13.0% |
| 2020 | 1.03 Billion USD | -11.29% |
| 2019 | 1.17 Billion USD | 7.01% |
| 2018 | 1.09 Billion USD | 21.13% |
| 2017 | 903.37 Million USD | 21.15% |
| 2016 | 745.69 Million USD | 18.68% |
| 2015 | 628.33 Million USD | 1.54% |
| 2014 | 618.78 Million USD | 7.51% |
| 2013 | 575.54 Million USD | 47.59% |
| 2012 | 389.97 Million USD | 108.95% |
| 2011 | 186.64 Million USD | 4.69% |
| 2010 | 178.28 Million USD | -45.45% |
| 2009 | 326.83 Million USD | 35.78% |
| 2008 | 240.71 Million USD | 0.31% |
| 2007 | 239.96 Million USD | 44.04% |
| 2006 | 166.6 Million USD | 118.85% |
| 2005 | 76.12 Million USD | 94.92% |
| 2004 | 39.05 Million USD | -17.37% |
| 2003 | 47.26 Million USD | -12.63% |
| 2002 | 54.1 Million USD | -3.44% |
| 2001 | 56.02 Million USD | 144.45% |
| 2000 | 22.92 Million USD | -47.57% |
| 1999 | 43.71 Million USD | 39.55% |
| 1998 | 31.32 Million USD | 58.0% |
| 1997 | 19.82 Million USD | 41.62% |
| 1996 | 14 Million USD | 13.82% |
| 1995 | 12.3 Million USD | 57.69% |
| 1994 | 7.8 Million USD | -17.89% |
| 1993 | 9.5 Million USD | 458.82% |
| 1992 | 1.7 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 350.37 Million USD | -7.18% |
| 2024 Q3 | 378.14 Million USD | -5.26% |
| 2024 Q2 | 399.13 Million USD | 13.92% |
| 2023 Q4 | 377.47 Million USD | -0.91% |
| 2023 Q1 | 287.59 Million USD | -5.61% |
| 2023 Q2 | 617.39 Million USD | 114.68% |
| 2023 FY | 1.66 Billion USD | 49.61% |
| 2023 Q3 | 380.93 Million USD | -38.3% |
| 2022 FY | 1.11 Billion USD | -5.28% |
| 2022 Q1 | 278.54 Million USD | -14.15% |
| 2022 Q2 | 276.21 Million USD | -0.84% |
| 2022 Q3 | 252.35 Million USD | -8.64% |
| 2022 Q4 | 304.67 Million USD | 20.73% |
| 2021 Q1 | 251.43 Million USD | -10.2% |
| 2021 FY | 1.17 Billion USD | 13.0% |
| 2021 Q2 | 303.71 Million USD | 20.8% |
| 2021 Q3 | 294.14 Million USD | -3.15% |
| 2021 Q4 | 324.46 Million USD | 10.31% |
| 2020 Q1 | 246.22 Million USD | -40.34% |
| 2020 Q2 | 247.52 Million USD | 0.53% |
| 2020 Q3 | 265.01 Million USD | 7.06% |
| 2020 Q4 | 279.99 Million USD | 5.65% |
| 2020 FY | 1.03 Billion USD | -11.29% |
| 2019 Q3 | 255.24 Million USD | -8.8% |
| 2019 Q2 | 279.87 Million USD | 25.45% |
| 2019 FY | 1.17 Billion USD | 7.01% |
| 2019 Q1 | 223.1 Million USD | -29.34% |
| 2019 Q4 | 412.73 Million USD | 61.7% |
| 2018 Q3 | 248.72 Million USD | -18.36% |
| 2018 Q1 | 225.15 Million USD | -18.24% |
| 2018 FY | 1.09 Billion USD | 21.13% |
| 2018 Q4 | 315.76 Million USD | 26.95% |
| 2018 Q2 | 304.64 Million USD | 35.31% |
| 2017 Q4 | 275.37 Million USD | 26.67% |
| 2017 FY | 903.37 Million USD | 21.15% |
| 2017 Q1 | 191.77 Million USD | -10.18% |
| 2017 Q2 | 218.84 Million USD | 14.11% |
| 2017 Q3 | 217.38 Million USD | -0.67% |
| 2016 Q4 | 213.51 Million USD | 18.46% |
| 2016 Q3 | 180.24 Million USD | -7.65% |
| 2016 FY | 745.69 Million USD | 18.68% |
| 2016 Q2 | 195.16 Million USD | 24.49% |
| 2016 Q1 | 156.77 Million USD | -3.88% |
| 2015 Q1 | 161.21 Million USD | -7.96% |
| 2015 FY | 628.33 Million USD | 1.54% |
| 2015 Q4 | 163.09 Million USD | 6.84% |
| 2015 Q3 | 152.65 Million USD | 0.85% |
| 2015 Q2 | 151.37 Million USD | -6.11% |
| 2014 FY | 618.78 Million USD | 7.51% |
| 2014 Q1 | 130.21 Million USD | -15.71% |
| 2014 Q2 | 153.42 Million USD | 17.83% |
| 2014 Q4 | 175.16 Million USD | 9.48% |
| 2014 Q3 | 159.99 Million USD | 4.28% |
| 2013 Q3 | 139.8 Million USD | 0.84% |
| 2013 Q1 | 163.42 Million USD | 20.24% |
| 2013 FY | 575.54 Million USD | 47.59% |
| 2013 Q4 | 154.47 Million USD | 10.5% |
| 2013 Q2 | 138.63 Million USD | -15.17% |
| 2012 FY | 389.97 Million USD | 108.95% |
| 2012 Q4 | 135.9 Million USD | 9.62% |
| 2012 Q3 | 123.97 Million USD | -18.56% |
| 2012 Q2 | 152.23 Million USD | 16.68% |
| 2012 Q1 | 130.47 Million USD | 3.84% |
| 2011 Q3 | 71.97 Million USD | 16.31% |
| 2011 Q4 | 125.64 Million USD | 74.56% |
| 2011 FY | 186.64 Million USD | 4.69% |
| 2011 Q2 | 61.88 Million USD | 21.01% |
| 2011 Q1 | 51.13 Million USD | 16.29% |
| 2010 FY | 178.28 Million USD | -45.45% |
| 2010 Q1 | 38.47 Million USD | -12.86% |
| 2010 Q4 | 43.97 Million USD | -10.71% |
| 2010 Q3 | 49.24 Million USD | 16.48% |
| 2010 Q2 | 42.28 Million USD | 9.89% |
| 2009 Q2 | 47.49 Million USD | 8.25% |
| 2009 Q1 | 43.87 Million USD | -71.81% |
| 2009 FY | 326.83 Million USD | 35.78% |
| 2009 Q4 | 44.15 Million USD | -8.32% |
| 2009 Q3 | 48.15 Million USD | 1.39% |
| 2008 Q1 | 62.4 Million USD | 22.92% |
| 2008 Q3 | 47.31 Million USD | -40.86% |
| 2008 Q4 | 155.66 Million USD | 229.02% |
| 2008 FY | 240.71 Million USD | 0.31% |
| 2008 Q2 | 79.99 Million USD | 28.18% |
| 2007 Q4 | 50.77 Million USD | -13.36% |
| 2007 Q2 | 68.93 Million USD | 6.31% |
| 2007 Q1 | 64.84 Million USD | 3.9% |
| 2007 FY | 239.96 Million USD | 44.04% |
| 2007 Q3 | 58.6 Million USD | -15.0% |
| 2006 Q4 | 62.41 Million USD | 2.03% |
| 2006 Q3 | 61.17 Million USD | 18.69% |
| 2006 Q2 | 51.53 Million USD | -3.95% |
| 2006 Q1 | 53.65 Million USD | 29.55% |
| 2006 FY | 166.6 Million USD | 118.85% |
| 2005 FY | 76.12 Million USD | 94.92% |
| 2005 Q4 | 41.41 Million USD | -11.29% |
| 2005 Q1 | 23.03 Million USD | -2.34% |
| 2005 Q2 | 24.83 Million USD | 7.84% |
| 2005 Q3 | 46.68 Million USD | 87.97% |
| 2004 Q4 | 23.58 Million USD | 30.78% |
| 2004 Q1 | 16.08 Million USD | 43.31% |
| 2004 FY | 39.05 Million USD | -17.37% |
| 2004 Q2 | 11.47 Million USD | -28.65% |
| 2004 Q3 | 18.03 Million USD | 57.17% |
| 2003 Q1 | 12.3 Million USD | -18.99% |
| 2003 Q3 | 7.45 Million USD | 73.2% |
| 2003 Q4 | 11.22 Million USD | 50.62% |
| 2003 FY | 47.26 Million USD | -12.63% |
| 2003 Q2 | 4.3 Million USD | -65.05% |
| 2002 FY | 54.1 Million USD | -3.44% |
| 2002 Q4 | 15.19 Million USD | 60.43% |
| 2002 Q1 | 12.61 Million USD | 10.19% |
| 2002 Q2 | 10.29 Million USD | -18.45% |
| 2002 Q3 | 9.47 Million USD | -7.97% |
| 2001 FY | 56.02 Million USD | 144.45% |
| 2001 Q3 | 14.5 Million USD | -6.58% |
| 2001 Q1 | 9.85 Million USD | 1.76% |
| 2001 Q2 | 15.52 Million USD | 57.48% |
| 2001 Q4 | 11.45 Million USD | -21.05% |
| 2000 Q2 | 28.96 Million USD | 1865.91% |
| 2000 FY | 22.92 Million USD | -47.57% |
| 2000 Q4 | 9.68 Million USD | 28.94% |
| 2000 Q1 | -1.64 Million USD | -117.27% |
| 2000 Q3 | 7.51 Million USD | -74.06% |
| 1999 FY | 43.71 Million USD | 39.55% |
| 1999 Q3 | 6.84 Million USD | -16.78% |
| 1999 Q2 | 8.22 Million USD | 6.24% |
| 1999 Q1 | 7.73 Million USD | -42.89% |
| 1999 Q4 | 9.49 Million USD | 38.78% |
| 1998 Q1 | 9.15 Million USD | 17.32% |
| 1998 FY | 31.32 Million USD | 58.0% |
| 1998 Q4 | 13.55 Million USD | 11.42% |
| 1998 Q3 | 12.16 Million USD | 18.56% |
| 1998 Q2 | 10.25 Million USD | 12.04% |
| 1997 Q1 | 5.81 Million USD | 5.72% |
| 1997 FY | 19.82 Million USD | 41.62% |
| 1997 Q4 | 7.8 Million USD | -7.45% |
| 1997 Q3 | 8.43 Million USD | 42.18% |
| 1997 Q2 | 5.93 Million USD | 1.92% |
| 1996 Q3 | 4.08 Million USD | -7.64% |
| 1996 Q4 | 5.5 Million USD | 34.86% |
| 1996 Q2 | 4.41 Million USD | 2.79% |
| 1996 Q1 | 4.3 Million USD | 38.71% |
| 1996 FY | 14 Million USD | 13.82% |
| 1995 Q2 | 3.5 Million USD | 0.0% |
| 1995 Q1 | 3.5 Million USD | -2.78% |
| 1995 Q4 | 3.1 Million USD | 0.0% |
| 1995 FY | 12.3 Million USD | 57.69% |
| 1995 Q3 | 3.1 Million USD | -11.43% |
| 1994 FY | 7.8 Million USD | -17.89% |
| 1994 Q4 | 3.6 Million USD | 20.0% |
| 1994 Q3 | 3 Million USD | 30.43% |
| 1994 Q2 | 2.3 Million USD | 43.75% |
| 1994 Q1 | 1.6 Million USD | 23.08% |
| 1993 Q4 | 1.3 Million USD | -51.85% |
| 1993 Q1 | 2.8 Million USD | 3.7% |
| 1993 FY | 9.5 Million USD | 458.82% |
| 1993 Q2 | 2.3 Million USD | -17.86% |
| 1993 Q3 | 2.7 Million USD | 17.39% |
| 1992 Q3 | 2 Million USD | -4.76% |
| 1992 FY | 1.7 Million USD | 0.0% |
| 1992 Q2 | 2.1 Million USD | 200.0% |
| 1992 Q1 | 700 Thousand USD | 0.0% |
| 1992 Q4 | 2.7 Million USD | 35.0% |
| 1991 Q4 | 700 Thousand USD | 600.0% |
| 1991 Q2 | 100 Thousand USD | 0.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -4274.504% |
| Agenus Inc. | 156.31 Million USD | -964.143% |
| Aptorum Group Limited | 431.37 Thousand USD | -385502.65% |
| Ardelyx, Inc. | 124.45 Million USD | -1236.541% |
| Dyadic International, Inc. | 2.89 Million USD | -57282.419% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -5156.953% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -638443.186% |
| Novavax, Inc. | 983.7 Million USD | -69.096% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -20479.055% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -8632.243% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -16641.194% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -207307.107% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | -914.803% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -20121.31% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -7914.092% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | 9.019% |
| AlloVir, Inc. | - USD | -Infinity% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -590.969% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -392212.5% |
| Bicycle Therapeutics plc | 26.97 Million USD | -6066.24% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -120436.594% |
| ChromaDex Corporation | 83.57 Million USD | -1890.433% |
| Chimerix, Inc. | 324 Thousand USD | -513296.605% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -4724.68% |
| CRISPR Therapeutics AG | 371.2 Million USD | -348.108% |
| Precision BioSciences, Inc. | 48.72 Million USD | -3313.723% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -2518.175% |
| Fortress Biotech, Inc. | 84.51 Million USD | -1868.224% |
| Fortress Biotech, Inc. | 84.51 Million USD | -1868.224% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -8163.724% |
| ImmuCell Corporation | 17.47 Million USD | -9420.584% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -7013.128% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 3.69 Billion USD | 54.99% |
| Innoviva, Inc. | 310.46 Million USD | -435.782% |
| IO Biotech, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 9.76 Million USD | -16941.338% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -1101492.715% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -1166.739% |
| ContextLogic Inc. | 287 Million USD | -479.584% |
| MiMedx Group, Inc. | 321.47 Million USD | -417.426% |
| MEI Pharma, Inc. | 65.29 Million USD | -2447.445% |
| NextCure, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 58.46 Thousand USD | -2845029.565% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -211798.726% |
| Opthea Limited | 261.85 Thousand USD | -635129.265% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -26621.365% |
| Pharming Group N.V. | 245.31 Million USD | -578.066% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -243801.026% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -3785.552% |
| PureTech Health plc | 3.33 Million USD | -49852.102% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -1323.149% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -17299.634% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | -843.872% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -106940.219% |
| Acelyrin, Inc. | - USD | -Infinity% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -64851.386% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -18845.387% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -33268000.0% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -1189.331% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -156235.056% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -1368.077% |
| Seer, Inc. | 15.18 Million USD | -10856.429% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -32363.017% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -6730.11% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 10 Thousand USD | -16633950.0% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -92311.389% |
| Akebia Therapeutics, Inc. | 194.62 Million USD | -754.681% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | -317.727% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -60168.297% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -2547.09% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -13709.921% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -198075.632% |
| Century Therapeutics, Inc. | 2.23 Million USD | -74325.28% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -7802.537% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -1543.453% |
| Autolus Therapeutics plc | 1.69 Million USD | -97862.603% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -3514.683% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -2446083.824% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | -876.888% |
| GRI Bio, Inc. | 21.76 Million USD | -7541.866% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -65388.747% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -77994.131% |
| INmune Bio, Inc. | 155 Thousand USD | -1073064.516% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -1209.314% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -74192.617% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -166240.5% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -19302.834% |
| Coherus BioSciences, Inc. | 257.24 Million USD | -546.625% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -47425.857% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -105178.797% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -21313.556% |
| Histogen Inc. | 3.76 Million USD | -44033.855% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -285105.176% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -1525959.633% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -424568.428% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -4809.841% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -24172.654% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | -954.47% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -1140781.344% |
| Apollomics, Inc. | 821 Thousand USD | -202507.186% |
| Amarin Corporation plc | 306.91 Million USD | -441.983% |
| Mesoblast Limited | 5.9 Million USD | -28083.751% |
| Turnstone Biologics Corp. | 19.3 Million USD | -8516.0% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -2016.507% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | -847.739% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.83 Billion USD | 9.114% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -2060.631% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | -319.426% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -124874.08% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -1088.902% |
| Insmed Incorporated | 305.2 Million USD | -445.007% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -8801.878% |
| OmniAb, Inc. | 34.16 Million USD | -4768.882% |
| Alector, Inc. | 97.06 Million USD | -1613.755% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -1216.766% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -1614856.311% |
| Zai Lab Limited | 266.71 Million USD | -523.654% |
| Revance Therapeutics, Inc. | 234.04 Million USD | -610.735% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -1279442.308% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -9434.046% |
| Veracyte, Inc. | 361.05 Million USD | -360.712% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -36078.832% |
| FibroGen, Inc. | 147.75 Million USD | -1025.809% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -1125305.095% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | 56.617% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -395948.81% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | -336.835% |
| TG Therapeutics, Inc. | 233.66 Million USD | -611.885% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | 46.497% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -106665.404% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -4770.165% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -1861.123% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -2796.707% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | -283.053% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -3616.608% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | -401.915% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -3014407.068% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -6296.727% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -18482177.778% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -50136.732% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | 87.319% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -1362096.181% |
| Pluri Inc. | 326 Thousand USD | -510146.933% |
| Prothena Corporation plc | 91.37 Million USD | -1720.515% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -2659.418% |
| Celularity Inc. | 22.77 Million USD | -7204.927% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -30198.816% |
| MeiraGTx Holdings plc | 14.01 Million USD | -11767.054% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | -566.888% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -2502.934% |
| Blueprint Medicines Corporation | 249.38 Million USD | -567.016% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -5267.727% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -22692.614% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -4485.541% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -33197.048% |
| Cytokinetics, Incorporated | 7.53 Million USD | -21990.372% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -79667.603% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -1232.91% |
| Evogene Ltd. | 5.64 Million USD | -29392.996% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -16545.702% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -17780.307% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -34554.271% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -4453.905% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -529646.815% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -83070.25% |
| MediciNova, Inc. | 1 Million USD | -166240.5% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -67877.319% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -9747365.573% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | -514.71% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | -77.369% |
| Mereo BioPharma Group plc | 10 Million USD | -16534.05% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -28990.679% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -7926.854% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | -515.486% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -59201.426% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | -244.836% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -1750852.632% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -34860.172% |
| Kezar Life Sciences, Inc. | 7 Million USD | -23662.929% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -7833.065% |
| aTyr Pharma, Inc. | 353 Thousand USD | -471119.547% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -10611.604% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -529646.815% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -13793788.382% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | -100.591% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -735243.136% |
| UroGen Pharma Ltd. | 82.71 Million USD | -1911.056% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -982.023% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -6015831.284% |
| Orgenesis Inc. | 530 Thousand USD | -313750.0% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | -888.134% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -655886.639% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | -763.479% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -735243.136% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -9747365.573% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -110572.322% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -31859.333% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -15078.438% |
| scPharmaceuticals Inc. | 13.59 Million USD | -12137.218% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -16495.879% |
| Daré Bioscience, Inc. | 2.8 Million USD | -59140.496% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -903924.457% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | 32.348% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -14264.465% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -2672.342% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -5539.234% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | 31.242% |
| DBV Technologies S.A. | 15.72 Million USD | -10476.075% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | 75.71% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -20676.98% |
| Molecular Templates, Inc. | 57.3 Million USD | -2802.672% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -1045.296% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -16387.313% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -24066.86% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -2731.376% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -257721.897% |
| Adagene Inc. | 18.11 Million USD | -9084.252% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -153634.288% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | -475.682% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | -565.341% |
| SciSparc Ltd. | 2.87 Million USD | -57677.18% |
| Vericel Corporation | 197.51 Million USD | -742.162% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -28074.204% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -2690.667% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -6411.411% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -1619.548% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -1556.992% |
| ADMA Biologics, Inc. | 258.21 Million USD | -544.194% |
| Clene Inc. | 654 Thousand USD | -254243.272% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -6506.564% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -3631.699% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -3226.81% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -1554484.112% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -1830.152% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -2275046.351% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -2746.201% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -14047.006% |
| Trevena, Inc. | 3.12 Million USD | -53128.96% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | -128.981% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -26353.642% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -21019.921% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -267328.457% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -30466.06% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -2271.448% |
| Celularity Inc. | 22.77 Million USD | -7204.927% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -41350.411% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -1063328.995% |
| Cibus, Inc. | 1.81 Million USD | -91446.78% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -46105.694% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -23122.183% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -86355.561% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | -111.187% |
| Eyenovia, Inc. | 3787.00 USD | -43923982.387% |
| Puma Biotechnology, Inc. | 235.63 Million USD | -605.918% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -1407.814% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -340761.68% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -2000.153% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -183691.706% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| Geron Corporation | 237 Thousand USD | -701758.65% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -24473.866% |
| Royalty Pharma plc | 2.35 Billion USD | 29.354% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -226561.77% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -4413.377% |
| Humacyte, Inc. | - USD | -Infinity% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -978373.529% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -138056.561% |
| Notable Labs, Ltd. | 310 Thousand USD | -536482.258% |
| Liquidia Corporation | 17.48 Million USD | -9411.694% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -153634.288% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -9069.313% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -89234.318% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -97027.751% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | 28.533% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -2306916.449% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -34860.172% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -5544583.333% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -10399.306% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -2470.831% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -390370.657% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | -316.522% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -4871.473% |
| Peak Bio, Inc. | 367.87 Thousand USD | -452063.359% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -5957.336% |
| Benitec Biopharma Inc. | 216 Thousand USD | -769994.907% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -187643.228% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | -35.642% |
| Immunome, Inc. | 14.01 Million USD | -11766.208% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -100286.542% |
| CervoMed Inc. | 7.14 Million USD | -23181.103% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -33757.216% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -58760.757% |
| Moolec Science SA | 905.04 Thousand USD | -183691.706% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -199826.083% |
| AnaptysBio, Inc. | 17.15 Million USD | -9595.197% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -67516.743% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -75406.355% |
| Lumos Pharma, Inc. | 2.05 Million USD | -81002.145% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -3984.463% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -79667.603% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -815294.608% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -1386070.833% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -665262.0% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | -340.393% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | -792.509% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -4058.513% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -139799.495% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -10665.679% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -291725.439% |
| HCW Biologics Inc. | 2.84 Million USD | -58433.623% |
| XOMA Corporation | 4.75 Million USD | -34860.172% |
| Nektar Therapeutics | 90.12 Million USD | -1745.726% |
| Arvinas, Inc. | 78.5 Million USD | -2018.987% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -3685.025% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -53662.282% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -254243.272% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -94897.43% |
| Synlogic, Inc. | 3.37 Million USD | -49244.557% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -452063.359% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -8240.796% |
| Krystal Biotech, Inc. | 50.69 Million USD | -3180.942% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -1039.061% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -30438.003% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -369860.433% |
| MannKind Corporation | 198.96 Million USD | -736.042% |
| Ikena Oncology, Inc. | 9.16 Million USD | -18059.443% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -1366.201% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | -483.358% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -41585025.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -3216.529% |
| REGENXBIO Inc. | 90.24 Million USD | -1743.271% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -74474.763% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -22442.418% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -220218.543% |
| Longeveron Inc. | 709 Thousand USD | -234512.835% |
| Repare Therapeutics Inc. | 51.13 Million USD | -3153.095% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | -33.786% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -14264.465% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -791997.619% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | 83.145% |
| Denali Therapeutics Inc. | 330.53 Million USD | -403.252% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -10106.844% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -61439.216% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -2048.325% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -1091158.282% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -11049.574% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -246330.37% |
| OmniAb, Inc. | 34.16 Million USD | -4768.882% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -7727.052% |
| Lipocine Inc. | -2.85 Million USD | 58448.341% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -74192.617% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -1915.98% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -1824.012% |
| Ocugen, Inc. | 6.03 Million USD | -27458.068% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -143793.166% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -4509.813% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -27613.227% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -262638.864% |
| Dominari Holdings Inc. | 2.03 Million USD | -81479.451% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | -43.513% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -6101.413% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | -185.798% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -13106.868% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -348622.222% |
| Iterum Therapeutics plc | - USD | -Infinity% |